ViroVet NV

Acronym: ViroVet

General Information

Identification Code: 984380024354-62

Website: http://www.virovet.com

Entity Form: NV

Registration Category: Companies & groups

Registration Date: 11/7/2016

Last Update: 2/13/2024

Mission & Interests

Goals: ViroVet is a pioneering company dedicated to the development of disruptive and innovative technologies for the control of viral diseases in livestock, with antiviral drugs for respiratory disease complexes and innovative vaccines for viral infections in swine leading the pipeline. The strategy of ViroVet is to provide novel solutions to be used alone or in combination with vaccines and biosecurity measures in order to provide livestock producers, national governments and international organizations with a multi-faceted arsenal of virus control weapons against endemic and epizootic viral diseases. It is clear that with the growing world population there is an increased demand for more protein-rich diets. With the increasing density of the livestock industry, the intensifying global trade and climate changes, there is an ever increased risk for the global spread of viral diseases, severely damaging livestock industry. ViroVet has already enlisted the support of a number of k (...)

Interests Represented: Promotes their own interests or the collective interests of their members

Interests:

Agriculture and rural development
Food safety
Public health
Research and innovation

Levels of Interest:

global

Activities

Main EU Legislative Proposals: ViroVet monitores everything linked to viral diseases in livestock and in particular epizootic and zoonotic outbreaks

Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Ambachtenlaan 1

Post Code: 3001

City: Heverlee

Country: BELGIUM

Phone:

Indic Phone: 32

Phone Number: 16299726

EU Office

Address: Ambachtenlaan 1

Post Code: 3001

City: Heverlee

Country: BELGIUM

Phone:

Indic Phone: 32

Phone Number: 16299726

Financial Data

Closed Year:

Start Date:

End Date:

Funding Sources:

Contributions:

Total Budget: 0

Grants:

Current Year:

Grants:

Membership Information

Members25 Percent: 2

Members: 2

Members F T E: 0.5

Info Members: Support for additional work on African Swine Fever and associated stockpiling of emergency-use product to stop and control outbreaks was anticipated, this would increase the working time to at least 3 FTE at 75%. To date the subsidy request to prepare for an ASF outbreak in Europe was denied, new approaches will be considered to continue our work on antiviral agents to block the disease and reduce the impact of a potential outbreak.